R01 CA167967/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2013	1
2014	5
2015	9
2016	4
2017	4
2018	5
2020	2
2024	0

1

Alternative splicing and cancer metastasis: prognostic and therapeutic applications.

Marzese DM, Manughian-Peter AO, Orozco JIJ, Hoon DSB. Marzese DM, et al. Clin Exp Metastasis. 2018 Aug;35(5-6):393-402. doi: 10.1007/s10585-018-9905-y. Epub 2018 May 29. Clin Exp Metastasis. 2018. PMID: 29845349 Review.

2

Liquid Biopsies for Assessing Metastatic Melanoma Progression.

Huynh K, Hoon DS. Huynh K, et al. Crit Rev Oncog. 2016;21(1-2):141-54. doi: 10.1615/CritRevOncog.2016016075. Crit Rev Oncog. 2016. PMID: 27481010 Free PMC article. Review.

3

Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer.

Marzese DM, Hoon DS. Marzese DM, et al. Expert Rev Mol Diagn. 2015 May;15(5):647-64. doi: 10.1586/14737159.2015.1027194. Epub 2015 Mar 22. Expert Rev Mol Diagn. 2015. PMID: 25797072 Free PMC article. Review.

4

Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients.

Huang SK, Hoon DS. Huang SK, et al. Mol Oncol. 2016 Mar;10(3):450-63. doi: 10.1016/j.molonc.2015.12.008. Epub 2015 Dec 17. Mol Oncol. 2016. PMID: 26778792 Free PMC article. Review.

5

CCR4 is a determinant of melanoma brain metastasis.

Klein A, Sagi-Assif O, Meshel T, Telerman A, Izraely S, Ben-Menachem S, Bayry J, Marzese DM, Ohe S, Hoon DSB, Erez N, Witz IP. Klein A, et al. Oncotarget. 2017 May 9;8(19):31079-31091. doi: 10.18632/oncotarget.16076. Oncotarget. 2017. PMID: 28415693 Free PMC article.

6

Epigenetic profiling for the molecular classification of metastatic brain tumors.

Orozco JIJ, Knijnenburg TA, Manughian-Peter AO, Salomon MP, Barkhoudarian G, Jalas JR, Wilmott JS, Hothi P, Wang X, Takasumi Y, Buckland ME, Thompson JF, Long GV, Cobbs CS, Shmulevich I, Kelly DF, Scolyer RA, Hoon DSB, Marzese DM. Orozco JIJ, et al. Nat Commun. 2018 Nov 6;9(1):4627. doi: 10.1038/s41467-018-06715-y. Nat Commun. 2018. PMID: 30401823 Free PMC article.

7

P-REX1 amplification promotes progression of cutaneous melanoma via the PAK1/P38/MMP-2 pathway.

Wang J, Hirose H, Du G, Chong K, Kiyohara E, Witz IP, Hoon DSB. Wang J, et al. Cancer Lett. 2017 Oct 28;407:66-75. doi: 10.1016/j.canlet.2017.08.001. Epub 2017 Aug 10. Cancer Lett. 2017. PMID: 28803992

8

RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb.

Wang J, Hua W, Huang SK, Fan K, Takeshima L, Mao Y, Hoon DS. Wang J, et al. Oncotarget. 2015 Oct 6;6(30):30165-77. doi: 10.18632/oncotarget.5030. Oncotarget. 2015. PMID: 26334503 Free PMC article.

9

Predominance of triple wild-type and IGF2R mutations in mucosal melanomas.

Iida Y, Salomon MP, Hata K, Tran K, Ohe S, Griffiths CF, Hsu SC, Nelson N, Hoon DSB. Iida Y, et al. BMC Cancer. 2018 Oct 30;18(1):1054. doi: 10.1186/s12885-018-4977-2. BMC Cancer. 2018. PMID: 30373548 Free PMC article.

10

Prospective Molecular Profiling of Circulating Tumor Cells from Patients with Melanoma Receiving Combinatorial Immunotherapy.

Lin SY, Chang SC, Lam S, Irene Ramos R, Tran K, Ohe S, Salomon MP, Bhagat AAS, Teck Lim C, Fischer TD, Foshag LJ, Boley CL, O'Day SJ, Hoon DSB. Lin SY, et al. Clin Chem. 2020 Jan 1;66(1):169-177. doi: 10.1373/clinchem.2019.307140. Clin Chem. 2020. PMID: 31672856 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Results by year